LivaNova (LIVN) Amortizatization of Intangibles (2015 - 2026)
LivaNova's (LIVN) quarterly Amortizatization of Intangibles came in at $2.7 million in Q1 2026, down 32.33% year-on-year from $4.0 million in Q1 2025, and up 3.64% quarter-over-quarter from $2.6 million in Q4 2025.
LivaNova (LIVN) Amortizatization of Intangibles (2015 - 2026) Analysis & Trends
LivaNova has disclosed Amortizatization of Intangibles across 12 years of filings, most recently posting $2.7 million for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $2.7 million, down 32.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.1 million (up 41.32% YoY), and the FY2025 annual result was $13.4 million, up 51.43% from the prior year.
- Amortizatization of Intangibles came in at $2.7 million for Q1 2026 at LivaNova, up from $2.6 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $4.6 million in Q2 2025 to a low of -$1.7 million in Q3 2024.
- The 5-year median for Amortizatization of Intangibles is $2.6 million (2023), against an average of $2.7 million.
- Across the five-year window, Amortizatization of Intangibles tumbled 178.46% in 2024 and soared 222.33% in 2025, its largest moves.
- LivaNova's Amortizatization of Intangibles stood at $3.1 million in 2022, then advanced by 8.06% to $3.4 million in 2023, then sank by 43.44% to $1.9 million in 2024, then jumped by 38.01% to $2.6 million in 2025, then advanced by 3.64% to $2.7 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.7 million (Q1 2026), $2.6 million (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 6.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 75.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | LivaNova | 4.34 Bn | 3.76 Bn | 243.75 Mn | 2.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.73 Mn |
| Mar 31, 2026 | 2.73 Mn |
| Dec 31, 2025 | 2.64 Mn |
| Dec 31, 2025 | 2.64 Mn |
| Sep 30, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.08 Mn |
| Jun 30, 2025 | 4.62 Mn |
| Jun 30, 2025 | 4.62 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Dec 31, 2024 | 1.91 Mn |
| Sep 30, 2024 | -1.70 Mn |
| Sep 30, 2024 | -1.70 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Jun 30, 2024 | 4.29 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Mar 31, 2024 | 4.33 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Dec 31, 2023 | 3.38 Mn |